Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
7.40
+0.90 (13.85%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $271.66 million as of June 26, 2026. Its market cap has increased by 269.74% in one year.
Market Cap
271.66M
Enterprise Value
640.58M
1-Year Change
269.74%
Ranking
Category
Stock Price
$7.40
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $271.66M, an increase of 486.56%. That is a compound annual growth rate of 28.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 271.66M | 18.82% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 257.64M |
| AC Immune | 243.04M |
| ALX Oncology Holdings | 240.87M |
| Fulcrum Therapeutics | 240.55M |
| Sol-Gel Technologies | 237.56M |
| Foghorn Therapeutics | 236.62M |
| Orchestra BioMed Holdings | 233.53M |
| Anavex Life Sciences | 228.44M |